Koninklijke Philips N.V. (PHG) on Wednesday announced that the FDA has granted 510(k) clearance for its new X11-4t Mini 3D transesophageal echocardiography (TEE) transducer.
TEE provides detailed images of the heart and its internal structures, aiding cardiologists in minimally invasive heart surgeries and procedures.
The company's X11-4t is designed to be easily tolerated by patients due to its 35% smaller size and pill-shaped design, with 87% of clinical respondents believing it may improve overall patient comfort.
The company said that this new transducer is compatible with Philips' premium cardiology ultrasound portfolio, including the EPIQ CVx and EchoNavigator image-guided therapy solution.
The company stated commercial availability of the Philips X11-4t ultrasound transducer is scheduled for 2024, pending the CE mark in Europe.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.